Genomic Classification of Cutaneous Melanoma - University of Miami
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
Untitled
Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors – Dependencies and Novel Pitfalls
Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Giancarlo Antonini (@gcarloantonini) / Twitter
Giancarlo CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI
Premio Roma - Albo d'oro 2019
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Giancarlo Cappellini - CONSULENTE INFORMATICO - PRISMA SOFTWARE SRL | LinkedIn
Genomic Classification of Cutaneous Melanoma - ScienceDirect
Giancarlo Antonini-Cappellini's research works
Genomic Classification of Cutaneous Melanoma. - Abstract - Europe PMC
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing in: European Journal of Endocrinology Volume 182 Issue 1 (2020)
Frontiers | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Frontiers | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Immunological validation of α2MB, Apo E and Apo A1 as potential diagnostic biomarkers.
